Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Decision Making in a World of Comparative Effectiveness Research: A Practical Guide > Legal Considerations in a World of Comparative Effectiveness Research
Decision Making in a World of Comparative Effectiveness Research: A Practical Guide |
Howard G. Birnbaum; Paul E. Greenberg
Springer Nature Singapore
Decision Making in a World of Comparative Effectiveness Research: A Practical Guide
Legal Considerations in a World of Comparative Effectiveness Research
Authors

Paul Kalb; Paul E. Greenberg; Crystal T. Pike

ARI Id

1664632746120_2503250

Access

Not Available Free

Pages

209-217

DOI

10.1007/978-981-10-3262-2_16

Chapter URL

https://rd.springer.com/chapter/10.1007/978-981-10-3262-2_16

Table of Contents of Book
Showing 1 to 20 of 26 entries
Chapters/HeadingsAuthor(s)PagesInfo
Front Matter
i-xvi
Front Matter
1-1
Introducing Decision Making in a World of Comparative Effectiveness Research
Howard G. Birnbaum; Paul E. Greenberg
3-4
Perspectives of Comparative Effectiveness Research from the World of Decision Making
Dave Nellesen; Howard G. Birnbaum; Paul E. Greenberg
5-14
Front Matter
15-15
Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with Mike Bonney
Michael W. Bonney; Howard G. Birnbaum
17-24
Perspectives on the Use of Comparative Effectiveness Research by Life Sciences Executives: An Interview with a Senior Executive at an International Life Science Company
Senior Life Sciences Executive; Howard G. Birnbaum; Francis Vekeman
25-37
Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies
Catherine Tak Piech; Patrick Lefebvre; Crystal T. Pike
39-62
Impact of Comparative Effectiveness Research on Drug Development Strategy and Innovation
Joshua P. Cohen; Joseph A. DiMasi; Kenneth I. Kaitin
63-73
Pricing of Pharmaceuticals: Current Trends and Outlook and the Role of Comparative Effectiveness Research
Christian Frois; Jens Grueger
75-93
Front Matter
95-95
Are Real-World Data and Evidence Good Enough to Inform Health Care and Health Policy Decision-Making?
Marc L. Berger; James Harnett
97-103
Translating Comparative Effectiveness Research Evidence to Real-World Decision Making: Some Practical Considerations
Richard J. Willke
105-116
Decision-Making by Public Payers
Louis F. Rossiter
117-136
Patient and Stakeholder Engagement in Designing Pragmatic Clinical Trials
Anna Hung; Carole Baas; Justin Bekelman; Marcy Fitz-Randolph; C. Daniel Mullins
137-152
Policy Considerations: Ex-US Payers and Regulators
Jipan Xie; Kalipso Chalkidou; Isao Kamae; Rebecca E. Dittrich; Rifaiyat Mahbub; Arjun Vasan et al.
153-166
Perspectives on the Common Drug Review Process at the Canadian Agency for Drugs and Technologies in Health
Patrick Lefebvre; Marie-Hélène Lafeuille; Sean Tiggelaar
167-179
Evaluating Non-Pharmaceutical Technologies at the Canadian Agency for Drugs and Technologies in Health
Patrick Lefebvre; Marie-Hélène Lafeuille; Sean Tiggelaar
181-189
Challenges and Opportunities in the Dissemination of Comparative Effectiveness Research Information to Physicians and Payers: A Legal Perspective
Mary E. Gately; Paul D. Schmitt
191-207
Legal Considerations in a World of Comparative Effectiveness Research
Paul Kalb; Paul E. Greenberg; Crystal T. Pike
209-217
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 20 of 26 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings